News and Announcements
PharmAust Limited (ASX:PAA) – CEO Interview
- Published February 26, 2014 12:41PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Pharmaust Limited (ASX:PAA) is an emerging biomedical and biotechnology company specialising in the acquisition and relaunch of existing marketed and approved drugs for oncology applications, making the entire development, regulatory and commercialisation process much faster.
Please listen to Dr. Roger Aston, Executive Chairman.
Executive Interviews
What is a Wholesale Investor in Australia? Complete 2026 Guide
What is a Wholesale Investor in Australia? A wholesale investor is an individual or entity that meets specific financial thresholds set out in the Corporations Act 2001 (Cth), qualifying them to access investment opportunities that are not available to general retail investors. These include private equity rounds, venture capital deals, pre-IPO placements, alternative funds, and […]
Why the 20-Year Hold Is the Secret to Australian Life Sciences Returns
Australia represents 0.3% of the world’s population. Yet it generates more than 3% of global research output. Cochlear implants. Wi-Fi. The HPV vaccine. These are not statistical anomalies. They are proof points of a structural advantage that Australia has failed to capitalise on. The country has a world-class research base. But it watches companies scale […]
The ‘Unused Billion’: How Points4Purpose is Disrupting the Flatlining Loyalty Market
The loyalty industry is plagued by “sameness,” leaving billions in value dormant. Ivan Schwartz’s Points4Purpose is disrupting this flatlining market by turning rewards into a liquid currency for rent, bills, and over 1.8 million charities.
Backed By Leading Investment Groups and Family Offices
